These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1143449

  • 1. Proceedings: Acute and chronic effects of the aldosterone antagonist spironolactone and its main metabolite canrenone on plasma aldosterone concentration, plasma renin activity, serum electrolytes and on the excretion of aldosterone, fluid and electrolytes in rats.
    Erbler HC, Hilfenhaus M.
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R52. PubMed ID: 1143449
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.
    Erbler HC, Wernze H, Hilfenhaus M.
    Eur J Clin Pharmacol; 1976 Feb 06; 9(4):253-7. PubMed ID: 971711
    [Abstract] [Full Text] [Related]

  • 4. A comparison of some extra-renal effects of spironolactone and canrenone.
    Huston GJ, Al-Dujaili EA.
    Br J Clin Pharmacol; 1979 Apr 06; 7(4):385-92. PubMed ID: 444357
    [Abstract] [Full Text] [Related]

  • 5. Spirolactones: clinical and pharmacologic studies.
    Corvol P, Claire M, Rafestin-Oblin ME, Michaud A, Roth-Meyer C, Menard J.
    Adv Nephrol Necker Hosp; 1977 Apr 06; 7():199-215. PubMed ID: 208407
    [No Abstract] [Full Text] [Related]

  • 6. Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method.
    Dahlöf CG, Lundborg P, Persson BA, Regårdh CG.
    Drug Metab Dispos; 1979 Apr 06; 7(2):103-7. PubMed ID: 38071
    [No Abstract] [Full Text] [Related]

  • 7. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
    Lammintausta R, Erkkola R.
    Int J Clin Pharmacol Biopharm; 1979 Jul 06; 17(7):294-8. PubMed ID: 489194
    [Abstract] [Full Text] [Related]

  • 8. [Clinical pharmacology. Pharmacokinetics and affinity of drugs for their receptors, Apropos of anti-aldosterone].
    Thebault JJ, Duchier J, Corvol P.
    Sem Hop Ther; 1976 Jul 06; 52(7-8):403-6. PubMed ID: 996562
    [No Abstract] [Full Text] [Related]

  • 9. Effect of spironolactone on the renin-aldosterone system in rats.
    Jiménez W, Martínez-Pardo A, Arroyo V, Gaya J, Rivera F.
    Rev Esp Fisiol; 1988 Sep 06; 44(3):257-63. PubMed ID: 3068736
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of aldosterone in normal subjects by Ro 12-2503 and spironolactone.
    Dux S, Rosenfeld J, Cocco G, Chu D, Gasser DF.
    Arzneimittelforschung; 1982 Sep 06; 32(2):164-9. PubMed ID: 7199923
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progestogens with antimineralocorticoid activity.
    Losert W, Casals-Stenzel J, Buse M.
    Arzneimittelforschung; 1985 Sep 06; 35(2):459-71. PubMed ID: 4039568
    [Abstract] [Full Text] [Related]

  • 14. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
    Finotti P, Palatini P.
    J Pharmacol Exp Ther; 1981 Jun 06; 217(3):784-90. PubMed ID: 6262496
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of spironolactone on electrolytes, renin, ACTH and corticosteroids in the rat.
    Chabert PR, Guelpa-Decorzant C, Riondel AM, Vallotton MB.
    J Steroid Biochem; 1984 Jun 06; 20(6A):1253-9. PubMed ID: 6087026
    [Abstract] [Full Text] [Related]

  • 19. Spironolactone response related to plasma canrenone concentration [proceedings].
    Hettiarachchi J, Ramsay LE.
    Br J Clin Pharmacol; 1979 Apr 06; 7(4):426P-427P. PubMed ID: 444376
    [No Abstract] [Full Text] [Related]

  • 20. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A, Suzuki H, Saruta T.
    J Lab Clin Med; 1993 Oct 06; 122(4):432-40. PubMed ID: 8228558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.